The Centers for Disease Control andPrevention (CDC) has released the nation’s numbers for the 2013-2014 influenza season, which show Americans were hit particularly hard due to the return of the H1N1 virus that caused the 2009 swine flu pandemic.
A new piece of legislation aims to stop prescription drug abuse by mandating that drugmakers registered under the Controlled Substances Act conduct background checks and perform employee drug testing for those with access to controlled substances.
Prophylactic treatment with an anti-inhibitor coagulant complex (FEIBA NF [Factor Eight Inhibitor Bypassing Activity], Baxter Healthcare) reduced the median annualized bleeding rate (ABR) more than three-fold as compared with on-demand treatment with the product to control acute hemorrhages, according to a Phase III study of 36 subjects with hemophilia A or B and inhibitory alloantibodies to factor VIII or factor IX.
The U.S. Department of Health and Human Services Office of Research Integrity (ORI) and Office for Human Research Protections (OHRP) released a web-based training video known as “The Research Clinic” to help teach clinical and social researchers how to better protect research subjects and avoid research misconduct.
Experimental and clinical data show that, compared with crystalloids, colloid fluid therapy mediates multiple beneficial effects in the lungs of patients suffering from acute respiratory distress
syndrome (ARDS), including reduced alveolar-capillary permeability, reduced histological damage, reduced inflammatory cell infiltration and faster hemodynamic stabilization.
The Centers for Medicare and MedicaidServices’ 2015 rate announcement and final call letter for Medicare Advantage and Part D programs implements several policies that will ensure beneficiaries have access to high-quality, high-value and low-cost options.
The U.S. Department of Health and Human Services (HHS) released a new security risk assessment (SRA) tool to assist healthcare providers in small- to medium-sized offices oversee risk assessments of their facilities.
The U.S. Department ofHealth and Human Services establisheda network of five clinical research organizations aimed to design and conduct clinical studies required to develop medical countermeasures, including vaccines, drugs and diagnostic tests, that can help protect Americans against bioterrorism, pandemic influenza and other widespread health emergencies.
Positive results have been shown with the completion of pathfinder2 for hemophilia A patients 12 years and older.
The Centers for Medicare andMedicaid Services (CMS) will increase the overall rate it pays Medicare Advantage plans by 0.4 percent in 2015.
Researchers in Finland and Estonia have discovered novel biological markers that are strongly indicative of the risk of dying from any disease within the next five years.
According to the U.S. Centers for Disease Control and Prevention, adult vaccination coverage remains well below Healthy People 2020 targets.
